Janux Therapeutics (JANX)
16.93
-0.27 (1.57%)
Upcoming Events
Latest Headlines
H.C. Wainwright Reiterates Buy Rating on Janux Therapeutics (JANX)
October 19, 2026 8:09 AM - StreetInsider
Janux Therapeutics doses first patient in JANX013 Phase 1 trial
September 14, 2026 8:01 AM - StreetInsider
Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX013
September 14, 2026 8:00 AM - BizWire
Wolfe Research Upgrades Janux Therapeutics (JANX) to Outperform, 'An ARM Out of the Penalty Box'
August 24, 2026 5:07 AM - StreetInsider
TD Cowen Assumes Janux Therapeutics (JANX) at Buy
August 22, 2026 7:54 AM - StreetInsider
Form SCHEDULE 13G/A Janux Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
August 14, 2026 4:15 PM - SEC Filing
Form SCHEDULE 13G/A Janux Therapeutics, Inc. Filed by: Janus Henderson Group Ltd.
August 13, 2026 12:42 PM - SEC Filing
Janux Therapeutics (JANX) PT Lowered to $35 at Stifel
August 7, 2026 10:28 AM - StreetInsider
Janux Therapeutics, Inc. (JANX) Misses Q2 EPS by 8c
August 6, 2026 6:09 PM - StreetInsider
Form 10-Q Janux Therapeutics, Inc. For: Jun 30
August 6, 2026 4:25 PM - SEC Filing
Form 8-K Janux Therapeutics, Inc. For: Aug 06
August 6, 2026 4:12 PM - SEC Filing
Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
August 6, 2026 4:02 PM - BizWire
Form 4 Janux Therapeutics, Inc. For: Jul 31 Filed by: Campbell David Alan
July 31, 2026 8:00 PM - SEC Filing
Form SCHEDULE 13G/A Janux Therapeutics, Inc. Filed by: BlackRock, Inc.
July 28, 2026 4:47 PM - SEC Filing
Full Article List
